Core Viewpoint - A class action lawsuit has been filed against SoundHound AI, Inc. for failing to disclose material weaknesses in its internal controls over financial reporting, particularly related to corporate acquisitions [1][2]. Group 1: Allegations - The lawsuit alleges that SoundHound did not disclose material weaknesses in its internal controls, which impaired its ability to account for corporate acquisitions [2]. - It is claimed that the company overstated its remediation efforts regarding these internal control weaknesses [2]. - The reported goodwill following the Amelia Acquisition was inflated and would require correction due to these weaknesses [2]. - SoundHound is expected to incur additional time and costs to account for the SYNQ3 and Amelia Acquisitions [2]. - The weaknesses increased the risk of the company being unable to file certain financial reports with the SEC in a timely manner [2]. Group 2: Stock Impact - On March 4, 2025, SoundHound announced it would be unable to timely file its Annual Report for 2024, citing the complexity of accounting for the SYNQ3 and Amelia Acquisitions [3]. - Following this announcement, SoundHound's stock price fell by $0.61, or 5.86%, closing at $9.72 per share [3]. Group 3: Class Action Participation - Shareholders may be eligible to participate in the class action against SoundHound AI, Inc. and can contact Robbins LLP if they wish to serve as lead plaintiff [4]. - Shareholders do not need to participate in the case to be eligible for recovery and can remain absent class members if they choose [4]. Group 4: Company Background - Robbins LLP is a recognized leader in shareholder rights litigation, dedicated to helping shareholders recover losses and improve corporate governance since 2002 [5].

Financial Performance - Cambium Networks Corporation (CMBM) is expected to report revenues of $34 million for Q4 2024, down from the previous estimate of $40-45 million and a decline from $40.2 million in the same quarter last year [1] - For the full year 2024, revenues are projected at $166 million, a decrease from $220.2 million in 2023, with a net loss estimated at $92 million or $3.29 per share, compared to a net loss of $77.4 million or $2.81 per share in 2023 [2] Impairment and Losses - The company anticipates non-cash charges of $27 million related to the impairment of goodwill and other intangible assets, primarily due to competitive market pressures and soft demand trends [2] - The widening losses in 2024 are attributed to both top-line decline and these impairment charges [2] Internal Control Issues - Cambium has identified issues in its internal control over financial reporting, particularly concerning allowance for credit losses, customer incentives, and IT general controls [3] - The company is taking steps to resolve these material weaknesses and implement additional processes [3] Competitive Environment - Cambium operates in a highly competitive environment, facing rapid technology shifts that require significant investment in research and development (R&D) to enhance product offerings [4] - The company's financial results and the need for R&D investments may strain its margins and impact long-term business prospects [4] Stock Performance - CMBM's stock has decreased by 83.8% over the past year, contrasting with the industry's growth of 41.1% [7] - Currently, Cambium holds a Zacks Rank of 3 (Hold) [8]

Core Viewpoint - Cambium Networks Corporation has filed a Notification of Late Filing for its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, due to the need for additional time to finalize its consolidated financial statements and internal control assessments [1][2]. Financial Performance - For the fiscal year ended December 31, 2024, Cambium Networks expects revenues of approximately $166.0 million, a decrease from $220.2 million in the prior year [8]. - The company anticipates a net loss of approximately $92.0 million, or $3.29 per diluted share, compared to a net loss of $77.4 million, or $2.81 per diluted share, for the fiscal year ended December 31, 2023 [8]. - For the quarter ended December 31, 2024, revenues are expected to be around $34.0 million, down from $40.2 million in the same quarter of the previous year [8]. - The anticipated net loss for the quarter is approximately $47.0 million, or $1.66 per diluted share, compared to a net loss of $52.9 million, or $1.91 per diluted share, for the quarter ended December 31, 2023 [8]. - Included in the net losses for both the quarter and year are approximately $27.0 million of non-cash charges related to impairment of goodwill and other intangible assets, attributed to weakened forecast demand and competitive pressures [8]. Internal Control Issues - The company has identified material weaknesses in its internal control over financial reporting, particularly concerning Allowance for Credit Losses, Customer Incentives, and Information Technology General Controls [3]. - Cambium Networks is implementing measures to improve its internal control over financial reporting, with oversight from the Audit Committee and assistance from external advisors [3]. Going Concern - The Annual Report on Form 10-K is expected to include disclosures regarding substantial doubt about the company's ability to continue as a going concern [6].

As filed with the Securities and Exchange Commission on December 1, 2023 Registration No. 333-275056 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT Under The Securities Act of 1933 CONDUIT PHARMACEUTICALS INC. (Exact name of Registrant as specified in its charter) | | | (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 4995 ...